Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Cabozantinib 60 MG
DRUG
2 trials
Sponsors
University of Bologna
, Istituto Clinico Humanitas
Conditions
Hepatocarcinoma
Non Small Cell Lung Cancer
Phase 2
Phase II Study With Cabozantinib in Patients With RET Positive NSCLC
NCT04131543
University of Bologna
Non Small Cell Lung Cancer
Start: 2019-08-07
End: 2022-08-07
Target: 25
Updated: 2019-10-18
Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma
NCT04435977
Istituto Clinico Humanitas
Hepatocarcinoma
Start: 2020-01-30
End: 2023-09-30
Target: 46
Updated: 2020-06-17